New synthetic molecules trigger immune response to HIV and prostate cancer

Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells.

Related Posts

Comments are closed.